AU2003216184A8 - Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof - Google Patents
Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereofInfo
- Publication number
- AU2003216184A8 AU2003216184A8 AU2003216184A AU2003216184A AU2003216184A8 AU 2003216184 A8 AU2003216184 A8 AU 2003216184A8 AU 2003216184 A AU2003216184 A AU 2003216184A AU 2003216184 A AU2003216184 A AU 2003216184A AU 2003216184 A8 AU2003216184 A8 AU 2003216184A8
- Authority
- AU
- Australia
- Prior art keywords
- derived
- nucleic acid
- acid molecules
- molecules encoding
- targeting proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35543202P | 2002-02-05 | 2002-02-05 | |
US60/355,432 | 2002-02-05 | ||
PCT/US2003/003550 WO2003066820A2 (en) | 2002-02-05 | 2003-02-05 | Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003216184A8 true AU2003216184A8 (en) | 2003-09-02 |
AU2003216184A1 AU2003216184A1 (en) | 2003-09-02 |
Family
ID=27734518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003216184A Abandoned AU2003216184A1 (en) | 2002-02-05 | 2003-02-05 | Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003216184A1 (en) |
WO (1) | WO2003066820A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10347710B4 (en) * | 2003-10-14 | 2006-03-30 | Johannes-Gutenberg-Universität Mainz | Recombinant vaccines and their use |
US20070269457A1 (en) * | 2006-05-16 | 2007-11-22 | The Buck Institute For Age Research | Immunotherapeutic compositions and methods |
WO2010129537A1 (en) * | 2009-05-05 | 2010-11-11 | The Johns Hopkins University | Phosphopeptides as melanoma vaccines |
US9518087B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
EP3909603A1 (en) | 2014-02-21 | 2021-11-17 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Glycotargeting therapeutics |
US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
US10370419B2 (en) | 2014-12-09 | 2019-08-06 | The Board Of Regents Of The University Of Textas System | Tuberculosis vaccine compositions and related methods |
JP2018515126A (en) * | 2015-05-22 | 2018-06-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Methods and compositions associated with antigen presenting proteins |
EP3638296A1 (en) | 2017-06-16 | 2020-04-22 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
US11773187B2 (en) | 2018-01-17 | 2023-10-03 | Nantbio, Inc. | Enhanced immunogenicity for GPI-anchored antigens |
EP4118210A4 (en) * | 2020-03-11 | 2024-04-17 | Nantcell Inc | Treatment of covid-19 and methods therefor |
CN116554300B (en) * | 2023-04-27 | 2023-10-24 | 湖北医药学院 | Polypeptide capable of interacting with clostridium difficile toxin TcdB and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001094949A2 (en) * | 2000-06-05 | 2001-12-13 | The Brigham And Women's Hospital, Inc. | Soluble cd1 compositions and uses thereof |
-
2003
- 2003-02-05 WO PCT/US2003/003550 patent/WO2003066820A2/en not_active Application Discontinuation
- 2003-02-05 AU AU2003216184A patent/AU2003216184A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003066820A3 (en) | 2003-11-13 |
AU2003216184A1 (en) | 2003-09-02 |
WO2003066820A2 (en) | 2003-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003216184A8 (en) | Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof | |
EP1414847A4 (en) | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | |
EP1414844A4 (en) | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | |
EP1379629A4 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
EP1383907A4 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
EP1383871A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
AU2003298570A8 (en) | Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof | |
EP1385991A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
EP1383908A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
EP1383877A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
EP1390486A4 (en) | Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof | |
EP1379678A4 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
EP1395674A4 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
EP1414422A4 (en) | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | |
EP1414863A4 (en) | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | |
EP1383876A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
AU2003241361A8 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
AU2003222241A8 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
EP1373294A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
AU2003221757A8 (en) | Nucleic acid molecules encoding human proteins, and uses thereof | |
AU2003251293A8 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
AU2003210945A8 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
EP1383788A4 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
AU2003225626A8 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
EP1404826A4 (en) | Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |